Toxoplasma F-box protein 1 is required for daughter cell scaffold function during parasite replication.


Journal

PLoS pathogens
ISSN: 1553-7374
Titre abrégé: PLoS Pathog
Pays: United States
ID NLM: 101238921

Informations de publication

Date de publication:
07 2019
Historique:
received: 20 12 2018
accepted: 27 06 2019
revised: 07 08 2019
pubmed: 28 7 2019
medline: 3 1 2020
entrez: 27 7 2019
Statut: epublish

Résumé

By binding to the adaptor protein SKP1 and serving as substrate receptors for the SKP1 Cullin, F-box E3 ubiquitin ligase complex, F-box proteins regulate critical cellular processes including cell cycle progression and membrane trafficking. While F-box proteins are conserved throughout eukaryotes and are well studied in yeast, plants, and animals, studies in parasitic protozoa are lagging. We have identified eighteen putative F-box proteins in the Toxoplasma genome of which four have predicted homologs in Plasmodium. Two of the conserved F-box proteins were demonstrated to be important for Toxoplasma fitness and here we focus on an F-box protein, named TgFBXO1, because it is the most highly expressed by replicative tachyzoites and was also identified in an interactome screen as a Toxoplasma SKP1 binding protein. TgFBXO1 interacts with Toxoplasma SKP1 confirming it as a bona fide F-box protein. In interphase parasites, TgFBXO1 is a component of the Inner Membrane Complex (IMC), which is an organelle that underlies the plasma membrane. Early during replication, TgFBXO1 localizes to the developing daughter cell scaffold, which is the site where the daughter cell IMC and microtubules form and extend from. TgFBXO1 localization to the daughter cell scaffold required centrosome duplication but before kinetochore separation was completed. Daughter cell scaffold localization required TgFBXO1 N-myristoylation and was dependent on the small molecular weight GTPase, TgRab11b. Finally, we demonstrate that TgFBXO1 is required for parasite growth due to its function as a daughter cell scaffold effector. TgFBXO1 is the first F-box protein to be studied in apicomplexan parasites and represents the first protein demonstrated to be important for daughter cell scaffold function.

Identifiants

pubmed: 31348812
doi: 10.1371/journal.ppat.1007946
pii: PPATHOGENS-D-18-02430
pmc: PMC6685633
doi:

Substances chimiques

F-Box Proteins 0
Protozoan Proteins 0
S-Phase Kinase-Associated Proteins 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1007946

Subventions

Organisme : NIGMS NIH HHS
ID : R01 GM084383
Pays : United States

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Annu Rev Microbiol. 2015;69:463-85
pubmed: 26332089
J Biol Chem. 2010 Aug 27;285(35):26852-60
pubmed: 20581113
J Immunol. 2017 Jan 15;198(2):808-819
pubmed: 27956528
Cell Microbiol. 2014 Jan;16(1):78-94
pubmed: 24015880
J Cell Sci. 2006 Jun 1;119(Pt 11):2236-45
pubmed: 16684814
Biophys Chem. 2008 Apr;134(1-2):64-71
pubmed: 18284940
Curr Opin Microbiol. 2007 Feb;10(1):83-9
pubmed: 16837236
J Biol Chem. 2012 Jul 20;287(30):25098-110
pubmed: 22648409
Microbiol Mol Biol Rev. 2002 Mar;66(1):21-38; table of contents
pubmed: 11875126
Mol Microbiol. 2017 Feb;103(4):618-634
pubmed: 27859784
PLoS Pathog. 2010 Jul 29;6(7):e1001029
pubmed: 20686666
Nature. 2000 Nov 16;408(6810):381-6
pubmed: 11099048
FEBS J. 2005 Oct;272(20):5101-9
pubmed: 16218944
Mol Biol Cell. 2004 Apr;15(4):1960-8
pubmed: 14742718
Nat Chem. 2014 Feb;6(2):112-21
pubmed: 24451586
Curr Opin Plant Biol. 2006 Dec;9(6):631-8
pubmed: 17005440
Science. 1987 Nov 27;238(4831):1275-8
pubmed: 3685978
Biochim Biophys Acta. 2013 Jun;1833(6):1329-37
pubmed: 23485398
PLoS Biol. 2015 Mar 03;13(3):e1002093
pubmed: 25734885
Int J Parasitol. 1982 Jun;12(2-3):221-6
pubmed: 7076393
Mol Biochem Parasitol. 2004 Sep;137(1):99-110
pubmed: 15279956
PLoS Pathog. 2014 Jun 12;10(6):e1004180
pubmed: 24945800
Mol Cell Biol. 2004 Feb;24(3):1058-69
pubmed: 14729953
Genome Biol. 2000;1(5):REVIEWS3002
pubmed: 11178263
J Cell Sci. 2000 Apr;113 ( Pt 7):1241-54
pubmed: 10704375
Nat Rev Cancer. 2014 Apr;14(4):233-47
pubmed: 24658274
J Immunol. 2008 Dec 15;181(12):8485-91
pubmed: 19050266
Int J Parasitol. 2009 Jul 1;39(8):877-82
pubmed: 19630138
Mol Cell Proteomics. 2015 Jan;14(1):66-80
pubmed: 25341530
Front Biosci. 2000 Apr 01;5:D391-405
pubmed: 10762601
mBio. 2015 Jun 16;6(3):e00557
pubmed: 26081631
Biochemistry. 2011 Mar 15;50(10):1700-13
pubmed: 21247092
J Cell Sci. 2008 May 1;121(Pt 9):1559-68
pubmed: 18411248
PLoS Pathog. 2010 Sep 09;6(9):e1001094
pubmed: 20844581
Cell Microbiol. 2006 Feb;8(2):339-52
pubmed: 16441443
Int J Parasitol. 2009 Oct;39(12):1385-94
pubmed: 19433092
Mol Biochem Parasitol. 2001 Jul;115(2):257-68
pubmed: 11420112
J Cell Sci. 2002 Mar 1;115(Pt 5):1017-25
pubmed: 11870220
Mol Biochem Parasitol. 2012 Aug;184(2):99-108
pubmed: 22659420
J Biol Chem. 2016 Feb 26;291(9):4268-80
pubmed: 26719340
Cell. 1997 Oct 17;91(2):209-19
pubmed: 9346238
Eukaryot Cell. 2009 Apr;8(4):530-9
pubmed: 19218426
Methods Enzymol. 2005;398:125-42
pubmed: 16275325
Nat Rev Mol Cell Biol. 2003 Dec;4(12):938-47
pubmed: 14685172
Mol Biol Cell. 2011 May;22(9):1575-84
pubmed: 21389113
Eukaryot Cell. 2009 Apr;8(4):520-9
pubmed: 19218423
EMBO J. 2018 Jan 17;37(2):269-281
pubmed: 29212814
Cytoskeleton (Hoboken). 2010 Sep;67(9):586-98
pubmed: 20658557
PLoS Pathog. 2011 Dec;7(12):e1002392
pubmed: 22144892
Cell. 1996 Jul 26;86(2):263-74
pubmed: 8706131
Cell Div. 2006 Dec 13;1:30
pubmed: 17166256
J Biol Chem. 2002 Oct 25;277(43):41240-6
pubmed: 12177058
Open Biol. 2013 Oct 09;3(10):130131
pubmed: 24107298
PLoS Pathog. 2017 Jul 3;13(7):e1006483
pubmed: 28671988
Microbiol Rev. 1992 Dec;56(4):529-42
pubmed: 1480107
J Biol Chem. 2017 Nov 10;292(45):18644-18659
pubmed: 28928220
J Parasitol. 1968 Apr;54(2):209-26
pubmed: 5647101
mBio. 2017 Nov 21;8(6):
pubmed: 29162714
Nucleic Acids Res. 2017 Jan 4;45(D1):D200-D203
pubmed: 27899674
Foodborne Pathog Dis. 2016 Mar;13(3):109-18
pubmed: 26854596
Cell Rep. 2018 Jul 17;24(3):744-754
pubmed: 30021170
PLoS One. 2008 Jun 11;3(6):e2386
pubmed: 18545708
Mol Biol Evol. 2012 Sep;29(9):2113-32
pubmed: 22389454
J Cell Sci. 1997 Jan;110 ( Pt 1):35-42
pubmed: 9010782
J Biol Chem. 2015 Jan 16;290(3):1712-28
pubmed: 25425642
Biochimie. 2015 Jul;114:134-46
pubmed: 25450248
Cell Host Microbe. 2015 Nov 11;18(5):621-33
pubmed: 26567513
J Biol Chem. 2017 Nov 17;292(46):18897-18915
pubmed: 28928219
Nat Rev Microbiol. 2014 Feb;12(2):125-36
pubmed: 24384598
Cell. 2016 Sep 8;166(6):1423-1435.e12
pubmed: 27594426

Auteurs

Carlos Gustavo Baptista (CG)

Department of Microbiology and Immunology, University at Buffalo School of Medicine, Buffalo, New York, United States of America.

Agnieszka Lis (A)

Department of Microbiology and Immunology, University at Buffalo School of Medicine, Buffalo, New York, United States of America.

Bowen Deng (B)

Department of Biochemistry & Molecular Biology, University of Georgia, Athens, Georgia, United States of America.

Elisabet Gas-Pascual (E)

Department of Biochemistry & Molecular Biology, University of Georgia, Athens, Georgia, United States of America.

Ashley Dittmar (A)

Department of Microbiology and Immunology, University at Buffalo School of Medicine, Buffalo, New York, United States of America.

Wade Sigurdson (W)

Department of Physiology and Biophysics, University at Buffalo School of Medicine, Buffalo, New York, United States of America.

Christopher M West (CM)

Department of Biochemistry & Molecular Biology, University of Georgia, Athens, Georgia, United States of America.

Ira J Blader (IJ)

Department of Microbiology and Immunology, University at Buffalo School of Medicine, Buffalo, New York, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH